Navigation Links
Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
Date:3/27/2013

g in the treatment and secondary prophylaxis of DVT and PE. Clinical data and the opinions of interviewed thought leaders indicate that current and emerging therapies have no advantage on this attribute over the sales-leading regimen of enoxaparin (Sanofi's Lovenox, generics) plus warfarin (Bristol-Myers Squibb's Coumadin, Eisai's Warfarin, generics).

According to insights from surveyed U.S. and European emergency room physicians and managed care organization (MCO) pharmacy directors, reducing the incidence of bleeding is one of the greatest unmet needs in the treatment and secondary prophylaxis of DVT/PE. Clinical data and the opinions of interviewed thought leaders indicate that the novel oral anticoagulants -- Xarelto, Eliquis, Boehringer Ingelheim's Pradaxa, Daiichi Sankyo's Lixiana -- have demonstrated the potential to partially fulfill this unmet need.

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
2. Surveyed U.S. and European Neurologists Agree that a Therapys Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
3. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
4. Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drugs Limited Post-Marketing Experience and Risks of Infection and Malignancy
5. Sound Physicians Enters Agreement to Provide Hospitalist Services at Broward Health
6. U.S. Physicians Report Diabetic Nephropathy as the Renal Condition with the Highest Unmet Need for Treatment
7. Physicians Adoption of Velcade for the Treatment of Chronic Graft Versus Host Disease Will Drive Growth In This Market Through 2021
8. Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project
9. Sunshine Act Survey: More Than 50% of Physicians Unprepared
10. iPad Altering Interaction between Pharma Sales Forces, Physicians, & Consumers
11. Harris Poll Study Links Emotional Connection to Physicians Trust in Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), ... commercialization of innovative therapies for the treatment of acute ... officer Howie Rosen will be presenting at ... Tim Morris will be presenting at JMP Securities ... as follows: Jefferies 2015 Healthcare Conference Date: ...
(Date:5/21/2015)... Research and Markets ( ... "Market Assessment of Respiratory Diagnostics in the ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service ... market in the United States ... service provides detailed analysis of the current and ...
(Date:5/21/2015)... WASHINGTON , May 21, 2015 ... following statement regarding the Medicare Part D offsets ... Century Cures initiative: "If the 21st Century ... billions from America,s premier health program – Medicare ... it may yield down the road. ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... France, Oct. 8 Vical Incorporated (Nasdaq: ... new nonclinical data,demonstrating that the company,s Vaxfectin(R) adjuvant ... disease vaccines and,peptide-based cancer vaccines. Alain P. Rolland, ... will present the data today,Wednesday, October 8, at ...
... 7 Prometheus Laboratories Inc., a,specialty pharmaceutical ... PROMETHEUS(R) IBS Diagnostic, the first and only ... findings suggest measurable,differences in the expression of ... non-IBS patients. The identification of these biomarkers,combined ...
Cached Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3
(Date:5/24/2015)... 2015 ProPin is a set of ... X. Utilize ProPin to pin point locations on a map, ... , ProPin allows users to choose from 30 simplistic presets ... With on-screen controls, video editors can easily manipulate ProPin presets as ... mark with absolute ease. , Using ProPin is easy, simply drag ...
(Date:5/24/2015)... WI (PRWEB) May 24, 2015 ... Health System CEO - The ... and honored at the fourth annual ... April 15 at Geneva National in ... school): ,     -Badger High School,         Jonathan ...
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation organized a ... learned through meditation and initiation at Special Holistic School ... Yogamaatha, a nine-year-old girl from North Carolina, stunned an ... the 2015 Business Advocacy Summit at Capitol Hill in ... In a demonstration that lasted three hours, Yogamaatha was ...
(Date:5/23/2015)... 2015 On Wednesday, May 20, 2015, ... has been the target of a sophisticated cyberattack,” and ... company’s ongoing Information Technology (IT) security efforts in the ... The most notable attack on health insurers was reported ... nation’s second largest health insurer, revealed that they had ...
(Date:5/23/2015)... A live auction will be held to sell over 5,200 ... medical facilities around the United States. Various types of ... exam and much more. , The live auction will ... at 9:00am CDT each day. The equipment is at their ... IL 60160. Anyone can participate in the auction including ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... for Childhood Cancer Research (NCCCR), a newly established division of Nemours ... in Wilmington, DE, has secured $1,020,000 in external funding for awards ... ... January 8, 2009-- The research team at the Nemours Center ...
... may reduce risk of cardiovascular disease , , THURSDAY, Jan. ... the millions of American men and women with type ... the day may be symptoms of obstructive sleep apnea, ... diabetics. , Based on strong preliminary evidence linking the ...
... Minnesota receives $20,000 to support local programs as part ... Special Olympics Minnesota recently received $20,000 ... Special Olympics International,s new national program. Project UNIFY is ... States in an effort to promote school communities where ...
... While the U.S. Food and Drug Administration Drug has quickened ... diseases for which new therapeutics are being developed has resulted ... for the Study of Drug Development. , The average time ... years in the 2005-07 period, but longer average clinical phase ...
... Limited (Nasdaq: WCRX ) announced today that ... Conference on Tuesday, January 13, 2009 at 3:00 p.m. ... Boissonneault, President and Chief Executive Officer and Paul Herendeen, ... will be webcast live for all interested parties at ...
... today announced that the second annual Health IT ... content partnership with Health Industry Insights, an IDC company, ... in Phoenix, Arizona from April 29-May 1, 2009. Originally ... moving to the four-diamond Phoenix resort in order to ...
Cached Medicine News:Health News:Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008 2Health News:Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008 3Health News:Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008 4Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 2Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 3Health News:Special Olympics Minnesota Launches Project UNIFY to Energize Youth 2Health News:New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD 2Health News:CrossTech Forums Announces Health IT Insight 2009 Moving to Arizona Grand Resort in Phoenix; Executive Summit to Take Place April 29-May 1 2Health News:CrossTech Forums Announces Health IT Insight 2009 Moving to Arizona Grand Resort in Phoenix; Executive Summit to Take Place April 29-May 1 3
A simple, in-office test for the detection of mononucleosis. Easy to use with fast, accurate results within minutes....
... The Wampole PreVue B. Burgdorferi Antibody ... membrane assay for the qualitative presumptive (first ... to B. burgdorferi in human serum or ... use and relative accuracy make the Wampole ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: